Home LiteratureArticle Details
PMID: 8565829 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.

Development (Cambridge, England) ·Vol. 122 ·No. 1 ·1996-01-00 ·Pages 181-93

Lund LR, Rømer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, Danø K, Werb Z

Abstract

Postlactational involution of the mammary gland is characterized by two distinct physiological events: apoptosis of the secretory, epithelial cells undergoing programmed cell death, and proteolytic degradation of the mammary gland basement membrane. We examined the spatial and temporal patterns of apoptotic cells in relation to those of proteinases during involution of the BALB/c mouse mammary gland. Apoptosis was almost absent during lactation but became evident at day 2 of involution, when beta-casein gene expression was still high. Apoptotic cells were then seen at least up to day 8 of involution, when beta-casein gene expression was being extinguished. Expression of sulfated glycoprotein-2 (SGP-2), interleukin-1 beta converting enzyme (ICE) and tissue inhibitor of metalloproteinases-1 was upregulated at day 2, when apoptotic cells were seen initially. Expression of the matrix metalloproteinases gelatinase A and stromelysin-1 and the serine proteinase urokinase-type plasminogen activator, which was low during lactation, was strongly upregulated in parallel starting at day 4 after weaning, coinciding with start of the collapse of the lobulo-alveolar structures and the intensive tissue remodeling in involution. The major sites of mRNA synthesis for these proteinases were fibroblast-like cells in the periductal stroma and stromal cells surrounding the collapsed alveoli, suggesting that the degradative phase of involution is due to a specialized mesenchymal-epithelial interaction. To elucidate the functional role of these proteinases during involution, at the onset of weaning we treated mice systemically with the glucocorticoid hydrocortisone, which is known to inhibit mammary gland involution. Although the initial wave of apoptotic cells appeared in the lumina of the gland, the dramatic regression and tissue remodeling usually evident by day 5 was substantially inhibited by systemic treatment with hydrocortisone. mRNA and protein for gelatinase A, stromelysin-1 and uPA were weakly induced, if at all, in hydrocortisone-treated mice. Furthermore, mRNA for membrane-type matrix metalloproteinase decreased after hydrocortisone treatment and paralleled the almost complete inhibition of activation of latent gelatinase A. Concomitantly, the gland filled with an overabundance of milk. Our data support the hypothesis that there are at least two distinct phases of involution: an initial phase, characterized by induction of the apoptosis-associated genes SGP-2 and ICE and apoptosis of fully differentiated mammary epithelial cells without visible degradation of the extracellular matrix, and a second phase, characterized by extracellular matrix remodeling and altered mesenchymal-epithelial interactions, followed by apoptosis of cells that are losing differentiated functions.

MeSH Terms
Animals Apoptosis/drug effects,genetics,physiology Caseins/genetics Caspase 1 Clusterin Cysteine Endopeptidases/genetics,physiology Endopeptidases/genetics,physiology Extracellular Matrix/metabolism Female Gelatinases/genetics Gene Expression/drug effects Glycoproteins/genetics,physiology Hydrocortisone/pharmacology In Situ Hybridization Lactation/genetics,physiology Mammary Glands, Animal/cytology,drug effects,physiology Matrix Metalloproteinase 2 Matrix Metalloproteinase 3 Metalloendopeptidases/genetics Mice Mice, Inbred BALB C Molecular Chaperones Pregnancy RNA, Messenger/genetics,metabolism Time Factors Urokinase-Type Plasminogen Activator/genetics
Chemicals
Caseins Clu protein, mouse Clusterin Glycoproteins Molecular Chaperones RNA, Messenger Endopeptidases Urokinase-Type Plasminogen Activator Cysteine Endopeptidases Caspase 1 Gelatinases Metalloendopeptidases Matrix Metalloproteinase 3 Matrix Metalloproteinase 2 Hydrocortisone
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Lund L R
Laboratory of Radiobiology and Environmental Health, University of California, San Francisco 94143-0750, USA.
Rømer J
Thomasset N
Solberg H
Pyke C
Bissell M J
Danø K
Werb Z
References (64)
64 references, click to expand
  1. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation.
    J Biol Chem. 1995 Jan 13;270(2):801-5 PMID: 7822314
  2. Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse.
    Int J Cancer. 1994 Nov 15;59(4):560-8 PMID: 7960227
  3. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.
    Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2730-4 PMID: 7708715
  4. Neutrophils express tumor necrosis factor-alpha during mouse skin wound healing.
    J Invest Dermatol. 1995 Jul;105(1):120-3 PMID: 7615965
  5. MACROPHAGES IN POST-SECRETORY MAMMARY INVOLUTION IN MICE.
    Anat Rec. 1964 May;149:99-111 PMID: 14158510
  6. Plasminogen activators in the mouse mammary gland. Decreased expression during lactation.
    J Biol Chem. 1989 May 5;264(13):7455-7 PMID: 2496128
  7. Growth factors in the regulation of pericellular proteolysis: a review.
    Cancer Res. 1989 May 15;49(10):2533-53 PMID: 2469534
  8. Cortisol alters gene expression during involution of the rat ventral prostate.
    Mol Endocrinol. 1989 Apr;3(4):703-8 PMID: 2498651
  9. Cell death by apoptosis during involution of the lactating breast in mice and rats.
    Am J Anat. 1989 May;185(1):19-32 PMID: 2782275
  10. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.
    Development. 1989 Feb;105(2):223-35 PMID: 2806122
  11. Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2.
    EMBO J. 1989 Nov;8(11):3287-94 PMID: 2583099
  12. Plasminogen activator inhibitors: hormonally regulated serpins.
    Mol Cell Endocrinol. 1990 Jan 2;68(1):1-19 PMID: 2105900
  13. Expression of extracellular matrix components is regulated by substratum.
    J Cell Biol. 1990 Apr;110(4):1405-15 PMID: 2182652
  14. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Endocrinology. 1990 May;126(5):2567-76 PMID: 2109689
  15. Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats.
    Biochem J. 1990 Jul 1;269(1):189-93 PMID: 2115769
  16. Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization.
    J Histochem Cytochem. 1991 Mar;39(3):341-9 PMID: 1899685
  17. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
    FASEB J. 1991 May;5(8):2145-54 PMID: 1850705
  18. New aspects of stroma-parenchyma relations in mammary gland differentiation.
    Int Rev Cytol. 1991;125:165-202 PMID: 2032784
  19. The plasminogen activator/plasmin system.
    J Clin Invest. 1991 Oct;88(4):1067-72 PMID: 1833420
  20. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds.
    J Invest Dermatol. 1991 Nov;97(5):803-11 PMID: 1919045
  21. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.
    J Cell Biol. 1991 Dec;115(6):1763-71 PMID: 1661735
  22. Metalloproteinases and their inhibitors in matrix remodeling.
    Trends Genet. 1990 Apr;6(4):121-5 PMID: 2132731
  23. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture.
    Development. 1991 Jun;112(2):439-49 PMID: 1794314
  24. Studies on mammary gland involution. I. On the ultrastructure of the lactating mammary gland.
    J Ultrastruct Res. 1968 Nov;25(3):193-213 PMID: 5715762
  25. Removal of basement membrane in the involuting breast.
    Lab Invest. 1976 May;34(5):455-62 PMID: 5627
  26. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator.
    N Engl J Med. 1977 May 5;296(18):1017-23 PMID: 66627
  27. Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue.
    Cell. 1979 Apr;16(4):929-40 PMID: 455456
  28. Multiple hormone interactions in the developmental biology of the mammary gland.
    Physiol Rev. 1980 Oct;60(4):1049-106 PMID: 7001510
  29. Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland.
    J Histochem Cytochem. 1982 Jul;30(7):667-76 PMID: 6179984
  30. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
    J Histochem Cytochem. 1984 Feb;32(2):219-29 PMID: 6198355
  31. Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse.
    J Cell Biol. 1984 Mar;98(3):894-903 PMID: 6365928
  32. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator.
    Eur J Biochem. 1985 Apr 15;148(2):225-32 PMID: 2985383
  33. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
    Proc Natl Acad Sci U S A. 1985 Aug;82(15):4939-43 PMID: 2991901
  34. Plasminogen activators, tissue degradation, and cancer.
    Adv Cancer Res. 1985;44:139-266 PMID: 2930999
  35. Characterization and expression of a murine gene homologous to human EPA/TIMP: a virus-induced gene in the mouse.
    EMBO J. 1987 Mar;6(3):651-7 PMID: 3034603
  36. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  37. Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody.
    J Histochem Cytochem. 1988 Jun;36(6):659-63 PMID: 3367051
  38. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity.
    J Biol Chem. 1988 Aug 15;263(23):11189-95 PMID: 2969891
  39. Posttranscriptional regulation of cellular gene expression by the c-myc oncogene.
    Mol Cell Biol. 1989 Jan;9(1):124-34 PMID: 2467185
  40. Localization of transforming growth factor-beta 1, -beta 2 and -beta 3 gene expression in bovine mammary gland.
    Mol Cell Endocrinol. 1991 Dec;82(2-3):191-8 PMID: 1794609
  41. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development.
    J Biol Chem. 1992 Apr 15;267(11):7856-62 PMID: 1373140
  42. Enhanced synthesis of gelatinase and stromelysin by myoepithelial cells during involution of the rat mammary gland.
    J Histochem Cytochem. 1992 May;40(5):697-703 PMID: 1315355
  43. The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells.
    J Biol Chem. 1992 Jul 15;267(20):13803-6 PMID: 1629180
  44. Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development.
    Development. 1991 Nov;113(3):867-78 PMID: 1821856
  45. Apoptotic cell death and tissue remodelling during mouse mammary gland involution.
    Development. 1992 May;115(1):49-58 PMID: 1638991
  46. Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro.
    J Cell Biol. 1992 Aug;118(3):727-39 PMID: 1639854
  47. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution.
    J Cell Biol. 1992 Sep;118(5):1271-82 PMID: 1512297
  48. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.
    Eur J Biochem. 1992 Sep 1;208(2):397-404 PMID: 1325906
  49. Cloning and sequencing of a cDNA encoding mouse stromelysin 1.
    Gene. 1992 Oct 21;120(2):321-2 PMID: 1398148
  50. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis.
    J Cell Biol. 1992 Nov;119(4):997-1002 PMID: 1429845
  51. Biology and biochemistry of proteinases in tumor invasion.
    Physiol Rev. 1993 Jan;73(1):161-95 PMID: 8419965
  52. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.
    Am J Pathol. 1993 Feb;142(2):359-65 PMID: 8434636
  53. Matrix metalloproteinases: a review.
    Crit Rev Oral Biol Med. 1993;4(2):197-250 PMID: 8435466
  54. Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.
    EMBO J. 1993 May;12(5):1835-45 PMID: 8491177
  55. Tumor cell interactions with the extracellular matrix during invasion and metastasis.
    Annu Rev Cell Biol. 1993;9:541-73 PMID: 8280471
  56. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development.
    J Cell Biol. 1994 Mar;124(6):1091-1102 PMID: 8132709
  57. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells.
    Oncogene. 1994 Apr;9(4):1213-23 PMID: 8134124
  58. Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein.
    J Biol Chem. 1994 Apr 8;269(14):10363-9 PMID: 8144618
  59. Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development.
    Mol Endocrinol. 1994 Feb;8(2):218-29 PMID: 8170478
  60. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.
    J Cell Biol. 1994 May;125(3):681-93 PMID: 8175886
  61. Induction of gene expression during involution of the lactating mammary gland of the rat.
    J Mol Endocrinol. 1994 Feb;12(1):47-60 PMID: 8185814
  62. A matrix metalloproteinase expressed on the surface of invasive tumour cells.
    Nature. 1994 Jul 7;370(6484):61-5 PMID: 8015608
  63. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.
    Am J Pathol. 1994 Oct;145(4):782-91 PMID: 7943170
  64. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix.
    Science. 1995 Feb 10;267(5199):891-3 PMID: 7531366
Article Info
Journal
Development (Cambridge, England)
Abbr.
Development
ISSN
0950-1991
Published
1996-01-00
Pages
181-93
Language
English
Region
England
NLM ID
8701744
PMCID
PMC2933211
Subset
IM
Grants
NCI NIH HHS · R01 CA057621 · United States
NCI NIH HHS · R01 CA057621-07 · United States
NCI NIH HHS · CA 57621 · United States
NCI NIH HHS · CA 5762151 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]